652
Participants
Start Date
March 31, 2007
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Paliperidone palmitate 25 mg eq.
Paliperidone palmitate 150 mg eq. i.m. Day 1 and 25 mg eq. i.m. Days 8, 36, 64
Paliperidone palmitate 150 mg eq.
Paliperidone palmitate 150 mg eq. i.m. Days 1, 8, 36, 64
Placebo
Placebo i.m. Days 1, 8, 36, 64
Paliperidone palmitate 100 mg eq.
Paliperidone palmitate 150 mg eq. i.m. Day 1 and 100 mg eq. i.m. Days 8, 36, 64
Anaheim
Cerritos
Escondido
Glendale
La Palma
Los Angeles
National City
San Diego
Santa Ana
Jacksonville
Kissimmee
Miami
North Miami
Atlanta
Hoffman Estates
Kingsport
Wichita
Lake Charles
Shreveport
Baltimore
Rockville
Cedarhurst
New York
Olean
Cincinnati
Moore
Charleston
Austin
Houston
San Antonio
Arlington
Richmond
Johor Bahru
Kota Bharu
Kuala Lumpur
Perak
Brasov
Bucharest
Craiova
Iași
Oradea
Sibiu
Tg Mures
Kazan'
Lipetsk
Moscow Russia
Nizny Novgorod
Saint Petersburg
Samara
St-Petersburg Na
St-Petresburg
Yaroslavl
Belgrade
Kragujevac
Gwangju
Inchun
Seoul
Changhua
Hualien City
Kaohsiung City
Taipei
Dnipro
Kharkiv
Kiev
Odesa
Simferopol
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY